Listen to expert faculty discuss recent advances in the management of sickle cell disease, including how to apply available treatment options for prevention and management of painful vaso-occlusive crises in patients with sickle cell disease. Claim your credit at pce.is/sickle.
In this second of 2 podcasts episodes on the management of painful vaso-occlusive crises in patients with sickle cell disease, listen to Alison Towerman, RN, MSN, CPNP, and Michael R. DeBaun, MD, MPH, discuss available treatment options for the prevention of painful vaso-occlusive events, and provide emergency department and outpatient setting recommendations on the proper use and indications for hydroxyurea, L-glutamine, and P-selecting blocking antibody crizanlizumab. This activity is available for 0.25 ANCC and 0.25 AAPA credits, with 0.25 credits applicable for pharmacology credit for NPs. To receive credit for this program, go to pce.is/sickle.
Contributors:
Michael R. DeBaun, MD, MPH
Director
Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease
Professor
Pediatrics and Medicine
Vice Chair for Clinical and Translational Research
Department of Pediatrics
J.C. Peterson Chair in Pediatrics
Nashville, Tennessee
Michael R. DeBaun, MD, MPH: consulting, speaker, and advisory board fees: Forma, GBT, Novartis, and Vertix.
Alison Towerman, RN, MSN, CPNP
Pediatric Nurse Practitioner
Department of Pediatrics, Division of Hematology/Oncology
Washington University School of Medicine in St. Louis
St. Louis, Missouri
Ms. Towerman has no relevant financial relationships to disclose.